NEW YORK, October 23, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Life Technologies Corporation (NASDAQ: LIFE), Community Health Systems, Inc. (NYSE: CYH), MEDNAX, Inc. (NYSE: MD), LifePoint Hospitals Inc. (NASDAQ: LPNT), and Covance Inc. (NYSE: CVD). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Life Technologies Corporation Research Report

On October 15, 2013, Life Technologies Corporation (Life Technologies) announced that it has extended its collaborative agreement with Japanese firm DNAVEC Corporation to launch CytoTune-iPS 2.0 Sendai Reprogramming Kit, the next-generation research technology that enables the most efficient method to develop induced pluripotent stem (iPS) cells from human somatic cells. According to Life Technologies, the newest kit doubles the number of colonies that can be produced and represents the latest in a series of products that are planned from the collaboration. Chris Armstrong, Ph.D., General Manager and Vice President of Primary and Stem Cell Systems at Life Technologies, stated, "This partnership enables both organizations to leverage their respective strengths." Armstrong continued, "DNAVEC's deep expertise in Sendai virus technology to develop breakthrough solutions is complemented by Life Technologies' global distribution channels that can rapidly put these novel products in the hands of customers to accelerate research and the promise of stem cells." The Full Research Report on Life Technologies Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/d5de_LIFE]

--

Community Health Systems, Inc. Research Report

On October 14, 2013, Community Health Systems, Inc. (Community Health Systems) announced that it will release its Q3 2013 results after the market close on Wednesday, October 30, 2013. The Company reported that the Q3 2013 conference call will be held on Thursday, October 31, 2013 at 10:00 a.m. CT / 11:00 a.m. ET. Community Health Systems reported that interested parties may use its website to access the live call or a replay until Saturday, November 30, 2013. The Full Research Report on Community Health Systems, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [ http://www.AnalystsCorner.com/r/full_research_report/7587_CYH]

--

MEDNAX, Inc. Research Report

On October 9, 2013, MEDNAX, Inc. (MEDNAX) announced that it will release its Q3 2013 results in the morning hours of Thursday, October 31, 2013. MEDNAX reported that the Q3 2013 conference call will be held on the same day at 10:00 a.m. EDT. The Company noted that interested parties may access the live and replay versions of the event through its Investor Relations website. The Full Research Report on MEDNAX, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/671d_MD]

--

LifePoint Hospitals Inc. Research Report

On October 11, 2013, LifePoint Hospitals Inc. (LifePoint Hospitals) announced that it will release its Q3 2013 before the market opens on Friday, October 25, 2013. LifePoint Hospitals reported that the Q3 2013 conference call will be held on the same day at 10:00 a.m. ET. The Company noted that interested parties may access its website for the live call or replay which will be available for 30 days after the completion of the call. The Full Research Report on LifePoint Hospitals Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/f06d_LPNT]

--

Covance Inc. Research Report

On October 8, 2013, Covance Inc. (Covance) reported that it has entered into a note purchase agreement for the private placement of senior notes totaling $250 million with a group of institutional investors. Covance reported that the notes, which are expected to be issued in November 2013, are in the following four series - $15 million bearing interest at 3.25% and maturing on November 15, 2018; $50 million bearing interest at 3.90% and maturing on November 15, 2020; $90 million bearing interest at 4.5% and maturing on November 15, 2023; and $95 million bearing interest at 4.65% and maturing on November 15, 2025. Alison Cornell, Corporate Vice President and Chief Financial Officer, Covance, said, "This private placement of debt allows Covance to secure long-term financing at historically low rates and provides flexibility to execute our growth strategy over the long-term." The Full Research Report on Covance Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/5691_CVD]

----

EDITOR NOTES:


        
        1) This is not company news. We are an independent source and our views do
          not reflect the companies mentioned.
        2) Information in this release is fact checked and produced on a best efforts
          basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human
          and are prone to make mistakes. If you notice any errors or omissions, please notify
          us below.
        3) This information is submitted as a net-positive to companies mentioned, to
          increase awareness for mentioned companies to our subscriber base and the investing
          public.
        4) If you wish to have your company covered in more detail by our team, or wish
          to learn more about our services, please contact us at
          pubco@EquityNewsNetwork.com.
        5) For any urgent concerns or inquiries, please contact us at
          compliance@EquityNewsNetwork.com.
        6) Are you a public company? Would you like to see similar coverage on your
          company? Send us a full investors' package to research@EquityNewsNetwork.com for
          consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

AnalystsCorner.com

SOURCE Analysts' Corner